Faculty of Dentistry, University of Granada, Colegio Máximo de Cartuja s/n, 18071 Granada, Spain.
Faculty of Dentistry, University of Granada, Colegio Máximo de Cartuja s/n, 18071 Granada, Spain.
J Dent. 2024 Nov;150:105333. doi: 10.1016/j.jdent.2024.105333. Epub 2024 Aug 30.
The aim of this systematic review was to demonstrate the efficacy of topical application of corticosteroids in remineralization of dental pulp tissues to preserve their vitality and function.
DATA, SOURCES AND STUDY SELECTION: An electronic search was performed using MEDLINE by PubMed, EMBASE, Web of Science (WOS), and Scopus databases. The inclusion criteria were in vitro studies that employed dental pulp tissue obtained from extracted healthy permanent human teeth and were subjected to topical administration of corticosteroids and evaluated tissue remineralization by performing any mineralization assay. A total of 11 studies were selected for inclusion. PRISMA guidelines were followed, and the methodological quality and risk of bias of the included studies were evaluated using the RoBDEMAT guidelines. Also, tables were designed for data extraction, including tissue mineralization and osteogenic differentiation as primary and secondary outcomes, respectively.
Alizarin Red S (ARS) has been able to demonstrate a possible mineralizing power of corticosteroids, applied at an adequate dose. The up-regulation of Alkaline phosphatase (ALP), osteocalcin (OCN), osteopontin (OSP), sialophosphoprotein (DSPP), runt-related transcription factor 2 (RUNX2), collagen type 1 alpha 1(COL1α1) and dentin matrix protein 1 (DMP-1) induced the osteogenic/odontogenic differentiation of dental pulp stem cells (DPSCs).
Deep carious lesions treatment is still challenging in restorative dentistry. Some treatments have been focused on dental pulp tissue remineralization to maintain the function and vitality. After corticosteroids topical application, mineral deposition and osteogenic differentiation have been detected.
本系统评价旨在展示皮质类固醇在牙髓组织再矿化中的应用效果,以保持其活力和功能。
通过 PubMed 的 MEDLINE、EMBASE、Web of Science (WOS) 和 Scopus 数据库进行电子检索。纳入标准为采用体外研究,使用取自健康恒磨牙的牙髓组织,并进行皮质类固醇局部给药,通过进行任何矿化检测评估组织再矿化。共选择了 11 项研究进行纳入。遵循 PRISMA 指南,并使用 RoBDEMAT 指南评估纳入研究的方法学质量和偏倚风险。还设计了表格用于提取数据,包括组织矿化和成骨分化分别作为主要和次要结果。
茜素红 S(ARS)已能够证明皮质类固醇在适当剂量下具有潜在的矿化能力。碱性磷酸酶(ALP)、骨钙素(OCN)、骨桥蛋白(OSP)、唾液酸磷蛋白(DSPP)、 runt 相关转录因子 2(RUNX2)、胶原类型 1α1(COL1α1)和牙本质基质蛋白 1(DMP-1)的上调诱导了牙髓干细胞(DPSCs)的成骨/成牙本质分化。
深龋病的治疗在修复牙科中仍然具有挑战性。一些治疗方法侧重于牙髓组织的再矿化,以保持其功能和活力。皮质类固醇局部应用后,检测到矿物质沉积和成骨分化。